Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7753 - 7760 of 12085 results
Moving on From "Natural," FDA Seeks Comments on What It Means to Be a "Healthy" Food
October 13, 2016| Blog| Viewpoint
New Rules for New York Employers Who Use Payroll Debit Cards and Direct Deposit
October 13, 2016| Blog| Viewpoint
Another Employee-Friendly Law: New California Law Aims to Keep Employment-Related Disputes Centered in California
October 13, 2016| Blog| Viewpoint
FTC Gets Creative to Help Failing Medical Practice
October 13, 2016| Blog| Viewpoint
U.S. Department of Energy Announces 16 New Innovative Projects in Energy Storage and Conversion
October 12, 2016| Blog| Viewpoint
Pleading Standard Defined– CAFC Holds that Joint Infringement Complaint Requires Identification of All Required Claim Steps
October 12, 2016| Blog| Viewpoint
What to Expect from a Health Plan Audit
October 12, 2016| News
FTC Fashions Creative Remedy to Permit Presumptively Anticompetitive Merger for Financially Failing Medical Practice
October 11, 2016| Alert| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|